SCRI Clinical Trials
Comprehensive Cancer Centers has been conducting phase I, Phase II and Phase III clinical trials for more than 20 years. Comprehensive is an established cancer research leader and has collaborated with Sarah Cannon Research Institute to enhance and expand clinical trials we offer to patients in Southern Nevada. Through this affiliation, Comprehensive will accelerate our ability to bring even more innovative therapies and the latest cutting-edge treatments to patients in our community.
Our cancer research program through SCRI provides access to the latest clinical trials to patients diagnosed with cancer. Our program with SCRI is part of an expansive research network with the goals of advancing therapies for patients and transforming cancer care within their own community, where the majority of people with cancer seek treatment.
Clinical trials rely on patient volunteers, referred to as study participants.
Click here to find a list of current, active clinical trials conducted by Comprehensive Cancer Centers.
How Do SCRI Clinical Trials Work?
A clinical trial is a medical research study. SCRI clinical trials, managed by your care team at Comprehensive Cancer Centers, are specifically designed to answer specific scientific questions that can improve the treatment and care of people with cancer. Trials are conducted for a variety of reasons, including to:
- Test new and better ways to prevent, screen, diagnose or treat cancer
- Test an existing cancer treatment on a different type of cancer
- Determine if an investigational therapy or procedure is more effective in treating a particular type of cancer than an existing
- therapy or procedure
- Understand how to use approved treatments in new combinations for better results
Clinical trials rely on patient volunteers, referred to as study participants. Every study participant is closely monitored with medical tests and exams before, during and after the clinical trial. Safety is always a top priority, and clinical trials are strictly managed by the FDA. Before a therapy is approved for testing in humans, the FDA ensures that it has gone through strict testing protocols. Click here to find a list of current, active clinical trials conducted by Comprehensive Cancer Centers.
Why are cancer clinical trials important?
Today’s clinical trials result in tomorrow’s treatment options. All of the standard cancer treatments used today are based on previous clinical trial results. Cancer clinical trials are important because they:
- Provide patients with access to the latest treatment options that are being explored
- Help patients contribute to medical knowledge and progress against cancer, which can improve care
- Provide critical data that can ultimately lead to new FDA-approved therapies for patients that are more effective and/or better tolerated than current treatments
To learn more about SCRI clinical trials, click here to visit our FAQ page, as well as our Video Resources page.